ACTA1 and ocular melanoma: Our results indicated that OM at a dose of 300 mg/kg had no significant effect on expression of TNF-α, IL-1, and α-SMA levels against the BDL-V rats, but significantly reduced the relative expression of TGF-β against the BDL-V rats (P ≤ 0.05) (Figure 8).